© 2024. 代谢相关脂肪性肝病临床科研与疾病管理大数据共享平台
| 论文标题 | 作者 | 发表时间 | 发表杂志 | 影响因子 |
|---|---|---|---|---|
| Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association | Kenneth Cusi, Manal F Abdelmalek, Caroline M Apovian, Kirthikaa Balapattabi, Raveendhara R Bannuru, Diana Barb, Joan K Bardsley, Elizabeth A Beverly, Karen D Corbin, Nuha A ElSayed, Scott Isaacs, Fasiha Kanwal, Elizabeth J Pekas, Caroline R Richardson, Michael Roden, Arun J Sanyal, Jay H Shubrook, Zobair M Younossi, Mandeep Bajaj. |
2025-07 |
Diabetes care |
16.6 |
| Exercise-induced adipokine Nrg4 alleviates MASLD by disrupting hepatic cGAS-STING signaling | Min Chen, Yang Li, Jie-Ying Zhu, Wang-Jing Mu, Hong-Yang Luo, Lin-Jing Yan, Shan Li, Ruo-Ying Li, Meng-Ting Yin, Xin Li, Hu-Min Chen, Liang Guo |
2025-02 |
Cell reports |
6.9 |
| A host enzyme reduces metabolic dysfunction-associated steatotic liver disease (MASLD) by inactivating intestinal lipopolysaccharide | Zhiyan Wang, Nore Ojogun, Yiling Liu, Lu Gan, Zeling Xiao, Jintao Feng, Wei Jiang, Yeying Chen, Benkun Zou, ChengYun Yu, Changshun Li, Asha Ashuo, Xiaobo Li, Mingsheng Fu, Jian Wu, Yiwei Chu, Robert S Munford, Mingfang Lu. |
2025-04 |
eLife |
8.7 |
| Hexokinase 2-mediated metabolic stress and inflammation burden of liver macrophages via histone lactylation in MASLD | Jinyang Li, Xiancheng Chen, Shiyu Song, Wangjie Jiang, Tianjiao Geng, Tiantian Wang, Yan Xu, Yongqiang Zhu, Jun Lu, Yongxiang Xia, Rong Wang. |
2025-03 |
Cell reports |
7.5 |
| FGF21 reverses MASH through coordinated actions on the CNS and liver | Jesse P Rose, Donald A Morgan, Andrew I Sullivan, Xiaorong Fu, Melissa Inigo-Vollmer, Shawn C Burgess, David K Meyerholz, Kamal Rahmouni, Matthew J Potthoff. |
2025-05 |
Cell metabolism |
27.7 |
| Hepatic AKAP1 deficiency exacerbates diet-induced MASLD by enhancing GPAT1-mediated lysophosphatidic acid synthesis | Linjie He, Xiaojuan She, Lifei Guo, Mingshu Gao, Shuangbin Wang, Zhenxing Lu, Haitao Guo, Renlong Li, Yongzhan Nie, Jinliang Xing, Lele Ji. |
2025-05 |
Nature communications |
14.7 |
| The Protective Effect of FOXO3 rs2802292 G-Allele on Food Intake in a Southern Italian Cohort Affected by MASLD | Rossella Donghia, Elisabetta Di Nicola, Rossella Tatoli, Giovanna Forte, Martina Lepore Signorile, Caterina Bonfiglio, Marialaura Latrofa, Katia De Marco, Andrea Manghisi, Vittoria Disciglio, Candida Fasano, Paola Sanese, Filomena Cariola, Antonia Lucia Buonadonna, Gianluigi Giannelli, Valentina Grossi, Cristiano Simone. |
2025-04 |
Nutrients |
4.8 |
| The Ability of the Triglyceride-Glucose (TyG) Index and Modified TyG Indexes to Predict the Presence of Metabolic-Associated Fatty Liver Disease and Metabolic Syndrome in a Pediatric Population with Obesity | Sofia Tamini, Adele Bondesan, Diana Caroli, Nicoletta Marazzi, Alessandro Sartorio. |
2025-03 |
Journal of clinical medicine |
3.0 |
| Linking Cardiovascular Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Role of Cardiometabolic Drugs in MASLD Treatment | Zisis M, Chondrogianni ME, Androutsakos T, Rantos I, Oikonomou E, Chatzigeorgiou A, Kassi E. |
2025-02 |
Biomolecules |
4.8 |
| Full-length 16S rRNA Sequencing Reveals Gut Microbiome Signatures Predictive of MASLD in children with obesity | Yu-Cheng Lin, Chi-Chien Wu, Yun-Er Li, Chun-Liang Chen, Chia-Ray Lin, Yen-Hsuan Ni |
2025-03 |
BMC Microbiology |
4 |
